Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Solid Biosciences Inc. | Director | Common Stock | 94.8K | $979K | $10.33 | May 2, 2024 | Direct |
Solid Biosciences Inc. | Director | Common Stock | 19.4K | $200K | $10.33 | May 2, 2024 | Indirect |
Solid Biosciences Inc. | Director | Common Stock | 9.51K | $98.2K | $10.33 | May 2, 2024 | Wife |
Solid Biosciences Inc. | Director | Restricted Stock Units | 0 | $0 | $10.33 | May 2, 2024 | Wife |
Solid Biosciences Inc. | Director | Director Stock Option (Right to Buy) | 34.4K | Jun 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SLDB | Solid Biosciences Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
SLDB | Solid Biosciences Inc. | May 2, 2024 | 3 | -$4.77K | 4 | May 6, 2024 | Director |
SLDB | Solid Biosciences Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Director |
SLDB | Solid Biosciences Inc. | Jan 27, 2024 | 5 | -$1.11K | 4 | Jan 30, 2024 | Director |
SLDB | Solid Biosciences Inc. | Jan 3, 2024 | 3 | -$6.05K | 4 | Jan 5, 2024 | Director |
SLDB | Solid Biosciences Inc. | Dec 2, 2023 | 2 | $0 | 4 | Dec 5, 2023 | Director |
SLDB | Solid Biosciences Inc. | Sep 2, 2023 | 2 | $0 | 4 | Sep 6, 2023 | Director |
SLDB | Solid Biosciences Inc. | May 2, 2023 | 6 | -$2.36K | 4 | Jun 8, 2023 | Director |
SLDB | Solid Biosciences Inc. | Mar 2, 2023 | 2 | $0 | 4 | Mar 6, 2023 | Director |
SLDB | Solid Biosciences Inc. | Jan 27, 2023 | 6 | -$11.4K | 4 | Jan 31, 2023 | Director |
SLDB | Solid Biosciences Inc. | Jan 3, 2023 | 2 | $0 | 4 | Jan 5, 2023 | Director |
SLDB | Solid Biosciences Inc. | Dec 2, 2022 | 2 | $0 | 4 | Dec 5, 2022 | Director |
SLDB | Solid Biosciences Inc. | May 2, 2022 | 1 | $0 | 4 | May 4, 2022 | CEO & President, Director |
SLDB | Solid Biosciences Inc. | Feb 10, 2022 | 1 | -$519 | 4 | Mar 8, 2022 | CEO & President, Director |
SLDB | Solid Biosciences Inc. | Jan 27, 2022 | 4 | $0 | 4 | Jan 31, 2022 | CEO & President, Director |